Stockreport

OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners

OKYO Pharma Limited - Ordinary Shares  (OKYO) 
PDF LONDON and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therap [Read more]